543. Protection From HIV Infection Using Single Chain Antibodies and siRNAs Against CCR3 and CCR5

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)39946-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Natural Anti-Ccr5 Antibodies in HIV-infection and -Exposure

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

HIV-1 Infection: The Functional Importance of SDF1, CCR2 and CCR5 in Protection and Therapeutics

Health Care : Current Reviews
2015English

Development of Tetravalent, Bispecific CCR5 Antibodies With Antiviral Activity Against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Vaccine Nanoparticles for Protection Against HIV Infection

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2017English

Single Chain Fragment Variable (scFv) Antibodies Targeting the Spike Protein of Porcine Epidemic Diarrhea Virus Provide Protection Against Viral Infection in Piglets

Viruses
VirologyInfectious Diseases
2019English

Protection From HIV Infection or AIDS?

Science
MultidisciplinaryPhilosophy of ScienceHistory
1993English

Immune Correlates of Protection From HIV Infection and AIDS

Immunology Today
1997English

Targeting CCR5 Trafficking to Inhibit HIV-1 Infection

Science advances
Multidisciplinary
2019English

Protecting From R5-Tropic HIV: Individual and Combined Effectiveness of a Hammerhead Ribozyme and a Single-Chain Fv Antibody That Targets CCR5

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy